NICE refuses yet another drug for R.A.

NICE have rejected yet another R.A. drug - this time for 'moderate to severe R.A.' It's RoActemra (tocilizumab), known as Actemra in the U.S. apparently. OK, so right now this isn't a huge personal concern for me - apart from the 'scrofulous pustule' and other minor unpleasant side effects, the methotrexate is doing its job; …